medroxyprogesterone acetate has been researched along with Precancerous Conditions in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (46.15) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Buca, D; D'Antonio, F; De Rocco, S; Dessole, M; Fanfani, F; Leombroni, M; Liberati, M; Lucidi, A; Nappi, L; Oronzii, L; Petrillo, M; Scambia, G | 1 |
| Chen, M; Jiang, W; Liao, X; Mao, A; Ou, C; Qin, Q; Tan, Q; Wei, C; Yang, C; Yang, W; Ye, X | 1 |
| Bai, Y; Guo, Q; Li, C; Li, M; Wang, C; Yan, L; Zhang, H; Zhao, X | 1 |
| Arnes, M; Borgfeldt, C; Lyså, LM; Straume, B; Ørbo, A | 1 |
| Branstetter, D; Dougall, WC; Erwert, R; Gonzalez-Suarez, E; Jacob, AP; Jones, J; Miller, R; Pinkas, J; Roudier-Meyer, MP | 1 |
| Castaneda, TA; Gambrell, RD; Massey, FM; Ricci, CA; Ugenas, AJ; Wright, JM | 1 |
| Schantz, HD; Trabal, JF; Valente, PT | 1 |
| Jax, JM; Kuntzman, TJ; Volk, EE | 1 |
| Miura, K; Nagasawa, H; Nakajima, K; Namiki, H; Niki, K; Noguchi, Y; Ohta, K | 1 |
| Aoki, M; Ishida, M; Nagasawa, H; Sakagami, N | 1 |
| Dallenbach-Hellweg, G | 1 |
| Fujii, M; Hagiwara, K; Nagasawa, H | 1 |
| Izutsu, T; Kagabu, T; Kurokawa, Y; Nishiya, I; Satoh, K; Yoshizumi, N | 1 |
2 review(s) available for medroxyprogesterone acetate and Precancerous Conditions
| Article | Year |
|---|---|
Reproductive and pregnancy outcomes of fertility-sparing treatments for early-stage endometrial cancer or atypical hyperplasia: A systematic review and meta-analysis.
Topics: Abortion, Spontaneous; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hyperplasia; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Precancerous Conditions; Pregnancy; Pregnancy Outcome | 2022 |
[Conservative organ-preserving measures in precancerous stages of endometrial cancer].
Topics: Adult; Endometrial Hyperplasia; Female; Humans; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Precancerous Conditions; Uterine Neoplasms | 1988 |
1 trial(s) available for medroxyprogesterone acetate and Precancerous Conditions
| Article | Year |
|---|---|
HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia.
Topics: Biomarkers; Biopsy; Dose-Response Relationship, Drug; Drug Resistance; Endometrial Hyperplasia; Endometrium; Female; Gene Expression Regulation; Humans; Inclusion Bodies; Levonorgestrel; Medroxyprogesterone Acetate; Middle Aged; Precancerous Conditions; Proteins; Risk; Treatment Outcome; WAP Four-Disulfide Core Domain Protein 2 | 2016 |
10 other study(ies) available for medroxyprogesterone acetate and Precancerous Conditions
| Article | Year |
|---|---|
A Novel Animal Model of Induced Breast Precancerous Lesion in Tree Shrew.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Drug Synergism; Estrogen Receptor alpha; Female; Keratin-5; Keratin-6; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Precancerous Conditions; Receptor, ErbB-2; Receptors, Progesterone; Tupaiidae | 2019 |
Dual-specificity phosphatase 6 predicts the sensitivity of progestin therapy for atypical endometrial hyperplasia.
Topics: Antineoplastic Agents, Hormonal; Biomarkers; Cell Line, Tumor; Drug Resistance, Neoplasm; Dual Specificity Phosphatase 6; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Immunohistochemistry; Medroxyprogesterone Acetate; Precancerous Conditions; Progestins; Treatment Outcome; Up-Regulation | 2015 |
RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Breast Neoplasms; Cell Proliferation; Cell Transformation, Neoplastic; Disease Models, Animal; Epithelial Cells; Female; Humans; Lung Neoplasms; Mammary Neoplasms, Experimental; Mammary Tumor Virus, Mouse; Medroxyprogesterone Acetate; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Invasiveness; Precancerous Conditions; Progesterone; Progestins; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B | 2010 |
Use of the progestogen challenge test to reduce the risk of endometrial cancer.
Topics: Adenocarcinoma; Aged; Endometrial Hyperplasia; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Precancerous Conditions; Progesterone; Prospective Studies; Risk; Uterine Neoplasms | 1980 |
Cytologic changes in cervical smears associated with prolonged use of depot-medroxyprogesterone acetate.
Topics: Adult; Contraceptive Agents, Female; Delayed-Action Preparations; False Positive Reactions; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Papanicolaou Test; Precancerous Conditions; Progesterone Congeners; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaginal Smears | 1998 |
Cytologic findings in cervical smears in patients using intramuscular medroxyprogesterone acetate (Depo-provera) for contraception.
Topics: Adolescent; Adult; Cervix Uteri; Contraceptive Agents, Female; Female; Glycogen; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Precancerous Conditions; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaginal Smears | 2000 |
Interrelationship between pituitary and ovarian hormones in normal and neoplastic growth of mammary glands of mice.
Topics: Animals; Cell Transformation, Neoplastic; DNA; DNA Replication; Estrogens; Female; Growth Hormone; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Ovary; Precancerous Conditions; Progesterone; Prolactin | 1986 |
Medroxyprogesterone acetate enhances spontaneous mammary tumorigenesis and uterine adenomyosis in mice.
Topics: Animals; Cell Transformation, Neoplastic; Endometriosis; Female; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Organ Size; Precancerous Conditions; Uterine Neoplasms | 1988 |
Inhibition by medroxyprogesterone acetate of precancerous mammary hyperplastic alveolar nodule formation in mice.
Topics: Animals; Antineoplastic Agents; Body Weight; Estrus; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Inbred Strains; Organ Size; Precancerous Conditions; Pregnancy; Prolactin | 1985 |
[Flow cytometric study on the action of progestogen in patients with adenocarcinoma and precancerous lesions of the endometrium].
Topics: Adenocarcinoma; Adult; Aged; Cell Cycle; DNA, Neoplasm; Female; Flow Cytometry; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Precancerous Conditions; RNA, Neoplasm; Software; Uterine Neoplasms | 1985 |